ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,314, issued on March 25, was assigned to THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (Philadelphia).
"EBNA1 inhibitors and their method of use" was invented by Troy E. Messick (Upper Darby, Pa.), Garry R. Smith (Royersford, Pa.), Allen B. Reitz (Lansdale, Pa.), Paul M. Lieberman (Wynnewood, Pa.), Mark E. McDONNELL (Lansdale, Pa.), Yan Zhang (Fort Washington, Pa.) and Venkata Velvadapu (Ankeny, Iowa).
According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions of the invention comprise EBNA1 inhibitors useful for the treatment of diseases caused by EBNA1 activity such as cancer, infectious mononucleosis, chronic fatigue syndrome, multip...